Home LiteratureArticle Details
PMID: 18042715 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes.

Yasui DH, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, Thatcher KN, Farnham PJ, Lasalle JM

Abstract

Mutations in MECP2 cause the autism-spectrum disorder Rett syndrome. MeCP2 is predicted to bind to methylated promoters and silence transcription. However, the first large-scale mapping of neuronal MeCP2-binding sites on 26.3 Mb of imprinted and nonimprinted loci revealed that 59% of MeCP2-binding sites are outside of genes and that only 6% are in CpG islands. Integrated genome-wide promoter analysis of MeCP2 binding, CpG methylation, and gene expression revealed that 63% of MeCP2-bound promoters are actively expressed and that only 6% are highly methylated. These results indicate that the primary function of MeCP2 is not the silencing of methylated promoters.

MeSH Terms
Binding Sites Chromatin Immunoprecipitation CpG Islands DNA Methylation Gene Expression Regulation Gene Silencing Humans Methyl-CpG-Binding Protein 2/genetics,metabolism Neurons/metabolism Promoter Regions, Genetic Rett Syndrome/genetics
Chemicals
Methyl-CpG-Binding Protein 2
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Yasui Dag H
Department of Medical Microbiology and Immunology, Rowe Program in Human Genetics, School of Medicine, University of California, 1 Shields Avenue, Davis, CA 95616, USA.
Peddada Sailaja
Bieda Mark C
Vallero Roxanne O
Hogart Amber
Nagarajan Raman P
Thatcher Karen N
Farnham Peggy J
Lasalle Janine M
References (44)
44 references, click to expand
  1. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
    Nature. 1998 May 28;393(6683):386-9 PMID: 9620804
  2. Duplication of the 15q11-13 region in a patient with autism, epilepsy and ataxia.
    Dev Med Child Neurol. 1994 Aug;36(8):736-42 PMID: 8050626
  3. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG.
    Mol Cell. 2005 Sep 2;19(5):667-78 PMID: 16137622
  4. Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2.
    J Biol Chem. 2007 May 18;282(20):15057-64 PMID: 17371874
  5. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.
    Nat Genet. 2005 Jan;37(1):31-40 PMID: 15608638
  6. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
    Hum Mol Genet. 2005 Feb 15;14(4):483-92 PMID: 15615769
  7. Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome.
    Genome Res. 2006 May;16(5):595-605 PMID: 16606705
  8. Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients.
    BMC Med Genet. 2006 Jul 21;7:61 PMID: 16859563
  9. Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations.
    BMC Med Genet. 2002 Nov 5;3:12 PMID: 12418965
  10. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells.
    Nat Genet. 2005 Aug;37(8):853-62 PMID: 16007088
  11. Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent.
    Mol Cell Biol. 2000 May;20(9):3316-29 PMID: 10757815
  12. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.
    Nat Genet. 1998 Jun;19(2):187-91 PMID: 9620779
  13. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain.
    Hum Genet. 2002 Jun;110(6):545-52 PMID: 12107440
  14. Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples.
    Hum Mol Genet. 2005 Mar 15;14(6):785-97 PMID: 15689352
  15. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.
    Hum Genet. 2005 Jan;116(1-2):91-104 PMID: 15549394
  16. Hypervariable allelic expression patterns of the imprinted IGF2 gene in tumor cells.
    Oncogene. 1998 Jan 8;16(1):113-9 PMID: 9467950
  17. 15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders.
    Hum Mol Genet. 2007 Mar 15;16(6):691-703 PMID: 17339270
  18. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.
    Mol Cell Biol. 2001 Dec;21(23):7913-22 PMID: 11689684
  19. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.
    Science. 2003 Oct 31;302(5646):890-3 PMID: 14593184
  20. The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells.
    J Neurobiol. 2003 Apr;55(1):86-96 PMID: 12605461
  21. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
    Nat Genet. 1999 Oct;23(2):185-8 PMID: 10508514
  22. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
    Hum Mol Genet. 2006 Jun 15;15(12):2003-14 PMID: 16682435
  23. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation.
    Neuron. 2006 Oct 19;52(2):255-69 PMID: 17046689
  24. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2.
    Science. 2003 Oct 31;302(5646):885-9 PMID: 14593183
  25. High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays.
    Methods Enzymol. 2004;376:315-34 PMID: 14975315
  26. Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers.
    Am J Hum Genet. 1998 May;62(5):1077-83 PMID: 9545402
  27. Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin.
    Mol Cell Biol. 2007 Feb;27(3):864-77 PMID: 17101771
  28. The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptations in vivo.
    Cell Mol Neurobiol. 1994 Oct;14(5):487-505 PMID: 7621509
  29. DNA methylation and chromatin modification.
    Curr Opin Genet Dev. 1999 Apr;9(2):158-63 PMID: 10322130
  30. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain.
    Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15536-41 PMID: 12432090
  31. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA.
    Nucleic Acids Res. 1992 Oct 11;20(19):5085-92 PMID: 1408825
  32. Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2.
    Genes Dev. 1998 Dec 1;12(23):3693-702 PMID: 9851976
  33. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2.
    Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17551-8 PMID: 16251272
  34. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2.
    Nucleic Acids Res. 1993 Oct 25;21(21):4886-92 PMID: 8177735
  35. Methylation-dependent silencing at the H19 imprinting control region by MeCP2.
    Nucleic Acids Res. 2002 Mar 1;30(5):1139-44 PMID: 11861904
  36. Brief report: duplication of chromosome 15q11-13 in two individuals with autistic disorder.
    J Autism Dev Disord. 1994 Aug;24(4):529-35 PMID: 7961335
  37. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations.
    Curr Opin Neurol. 2001 Apr;14(2):171-6 PMID: 11262731
  38. Reversal of neurological defects in a mouse model of Rett syndrome.
    Science. 2007 Feb 23;315(5815):1143-7 PMID: 17289941
  39. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome.
    Nat Genet. 2007 Apr;39(4):457-66 PMID: 17334365
  40. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.
    Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1931-6 PMID: 17267601
  41. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection.
    Nat Genet. 2006 Aug;38(8):910-6 PMID: 16845400
  42. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation.
    J Biol Chem. 2003 Aug 22;278(34):32181-8 PMID: 12788925
  43. Suz12 binds to silenced regions of the genome in a cell-type-specific manner.
    Genome Res. 2006 Jul;16(7):890-900 PMID: 16751344
  44. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA.
    Cell. 1992 Jun 12;69(6):905-14 PMID: 1606614
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
1091-6490
Published
2007-12-04
Epub
2007-00-27
Pages
19416-21
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC2148304
Subset
IM
Grants
NICHD NIH HHS · R01 HD041462-05 · United States
NINDS NIH HHS · R01 NS041462 · United States
NICHD NIH HHS · R01 HD048799-03 · United States
NCRR NIH HHS · C06 RR12088 · United States
NICHD NIH HHS · R01 HD/NS41462 · United States
NICHD NIH HHS · R01 HD041462-04 · United States
NCRR NIH HHS · C06 RR012088 · United States
NICHD NIH HHS · R01 HD048799 · United States
NICHD NIH HHS · R01 HD041462 · United States
Databases
GEO
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com